Among the roles previously demonstrated for H19 as a modulator of cancer cells, one mechanism of action in the nuclear compartment involves the epigenetic modulation of the expression of Nkd1, an inhibitor of Wnt pathway. This evidence concerns the gene NKD1 and cancer.